STD Panel (Sexually Transmitted Diseases Panel)

The Chlamydia Trachomatis, IgG test analyzes the levels of chlamydia antibodies IgG in the blood. The IgG antibody detection is a marker for a chlamydia-positive immune response, either for ongoing (chronic) or past infections. IgG antibodies against chlamydia trachomatis can be detected within 2-4 weeks after exposure and remain detectable even after the person has been treated successfully. However, abnormal results do not confirm an active infection, as IgG antibodies can persist even after successful treatment.

The VDRL-RPR (Rapid Plasma Reagin) test looks for antibodies (specific proteins) that react to syphilis in the blood. This means the test doesn't find the actual bacteria that cause syphilis. Instead, it looks for antibodies against substances given off by cells that have been harmed by the bacteria.  Antibodies are a specific type of protein produced by your immune system to fight off any invaders, such as bacteria, viruses, or toxins. Detecting these antibodies can help your doctors know if you have syphilis. Untreated syphilis can spread to your eyes, blood vessels, heart, and brain. But it can be easily cured if treated in the early stages.

A Treponema Pallidum Hemagglutination test analyzes the presence of antibodies in the blood that are specifically directed against Treponema pallidum, the bacteria that causes syphilis, a sexually transmitted disease (STD). The presence of Treponema pallidum antibodies indicates that the individual has been exposed to the bacterium, either recently or in the past. Detecting these antibodies can help your doctors know if you have syphilis. Untreated syphilis can spread to your eyes, blood vessels, heart, and brain. A Treponema Pallidum Hemagglutination test can help in early diagnosis and ensure prompt treatment to prevent complications from syphilis.

An HIV Combo (Antigen And Antibody) Test simultaneously detects HIV p24 antigen and antibodies associated with HIV 1 & 2. The HIV p24 antigen is the most abundant HIV protein and its detection is used clinically to diagnose an HIV infection early on since HIV-specific antibodies are not detectable in a very recently acquired infection. HIV-1 was discovered first and is the most widespread, whereas HIV-2 is more than 55% genetically different from HIV-1. The transmission rate of HIV-2 is also slower than HIV-1. 

The Herpes Simplex Virus 1 & 2, IgM test is designed to detect IgM antibodies that are produced as a body's first response to a HSV infection. IgM antibodies may take up to 10 days to develop. Also, these antibodies are usually present in higher concentrations shortly after an infection and eventually decrease after a time period (7-10 days). Therefore, the presence of HSV-1 or HSV-2 IgM antibodies typically suggests a recent infection.

Early detection allows doctors to detect symptoms quickly and provide necessary medical interventions to individuals suffering from HSV infection, leading to better outcomes and improved quality of life.

The Herpes Simplex Virus 1 & 2, IgG test determines the presence of IgG antibodies against HSV-1 and HSV-2  in response to the Herpes infection. Your body begins to make two relevant types of HSV-1 antibody or HSV-2 antibody around 18 to 21 days after you are exposed to the virus and remains in the body for life. The presence of IgG antibodies generally indicates past exposure and immunity against Herpes infection.